The South Korea antibiotics market size stood at around USD 1.3 billion in 2019 and is projected to reach xx billion by 2028, exhibiting a CAGR of around xx% during the forecast period.
Antibiotics are also known as an antibacterial agent that has the ability to destroy or slow down the growth of bacteria and are widely used for the treatment and prevention of diseases caused by bacteria such as, Staphylococci, Streptococci, or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). Some of the common infections treated with antibiotics are conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, urinary tract infection, bronchitis, streptococcal pharyngitis, and others.
With the urbanization and destruction of natural habitats, climate change, and changing ecosystems, there is an emergence of infectious diseases. Mounting number of patients suffering from infectious diseases and diagnostic device developments drive the market.
Clinical trials are being conducted by many pharmaceuticals companies will also boost up the antibiotics market growth. In addition, advances in antibiotic drugs and new combination therapies to treat antibiotic-resistance can advance the treatment landscape and be a factor that propels the market growth.
Development of antibiotic resistance and increase in cost of drug approval restrain the market. Technologies require for antibody production is another substantial burden on market players.